A Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Divarasib in Healthy Participants
Status:
COMPLETED
Trial end date:
2025-02-11
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, two-period, fixed sequence drug-drug interaction study to evaluate the impact of multiple doses of Itraconazole on the pharmacokinetics (PK) and safety of Divarasib in healthy participants.